DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Geron Corp (NASDAQ: GERN)

3.95 -0.08 (-1.87%)

REAL-TIME: Last trade at

Extended Hours: $3.95 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

GERN $3.95 -1.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.02
Previous Close $4.02
Daily Range $3.89 - $4.06
52-Week Range $1.76 - $4.49
Market Cap $623.7M
P/E Ratio -17.48
Dividend (Yield) $0.00 (0.0%)
Volume 1,339,335
Average Daily Volume 2,528,522
Current FY EPS -$0.07

Sector

Healthcare

Industry

Drug Makers

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website: http://www.geron.com/

News & Commentary Rss Feed

The Reason Behind Geron Corporation's 25% Catapult Higher in March

A favorable fourth-quarter earnings report and an even more favorable view from one Wall Street firm set the stage for a great March for Geron. But, can the good times keep rolling?

Some Answers From Dr. Scarlett, CEO Of Geron

Asterias Biotherapeutics' Stem Cell Program Is Dead On Arrival

Health Care Sector Update for 05/01/2015: GERN,NKTR,TLOG

Geron Q1 Loss In Line with Estimates, Restructuring on Track - Analyst Blog

AIM's Tory Williams Unites Patient Advocacy With Stem Cell Funding In The Deep South

The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pha

The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases

Health Care Sector Update for 04/21/2015: GERN, MYL, TEVA, NVGN, JNJ

Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog

Oppenheimer Is Excited About These 3 Biotech Stocks

3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog

See More GERN News...

GERN's Top Competitors

GERN $3.95 (-1.87%)
Current stock: GERN
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB